Catalent
CTLT
#1737
Rank
ยฃ8.64 B
Marketcap
ยฃ47.64
Share price
0.00%
Change (1 day)
8.87%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Net assets

Net assets on the balance sheet as of September 2024 : ยฃ2.65 Billion

According to Catalent's latest financial reports the company has ยฃ2.65 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Catalent - Net assets on balance sheet (from 2013 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$ยฃ3.62 B-7.62%
2022-06-30$ยฃ3.92 B27.05%
2021-06-30$ยฃ3.09 B9.21%
2020-06-30$ยฃ2.82 B57%
2019-06-30$ยฃ1.80 B119.1%
2018-06-30$ยฃ0.82 B47.91%
2017-06-30$ยฃ0.55 B16.59%
2016-06-30$ยฃ0.47 B18.05%
2015-06-30$ยฃ0.40 B-285.99%
2014-06-30$-ยฃ0.22 Billion-19.47%
2013-06-30$-ยฃ0.27 Billion20.72%
2012-06-30$-ยฃ0.23 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Supernus Pharmaceuticals
SUPN
ยฃ0.78 B-70.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.13 Billion-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ2.97 B 11.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
ยฃ53.91 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA